Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
To supply Pur Q fused quartz vials in EZ-fill packaging format to help streamline fill-finish operations for early phase drug development.
October 14, 2020
By: Contract Pharma
Contract Pharma Staff
Momentive Technologies and Stevanato Group have entered a collaboration agreement to supply Momentive Technologies’ Pur Q fused quartz vials in the Stevanato Group’s EZ-fill packaging format. Momentive Technologies’ Pur Q vials are the first ultra-high-purity fused quartz vials available for pharmaceutical packaging. Stevanato Group’s EZ-fill secondary packaging solution provides an integrated, ready-to-use solution for aseptic fill-finish operations. Combined, the offerings aim to help biopharma companies improve the reliability and speed of drug development and production of medications via highly stable primary packaging and an efficient secondary packaging method. Stevanato designed its EZ-fill secondary packaging to mitigate the risk of breakages, cosmetic issues and particulate generation during fill-finish operations. The packaging stores vials safely in a tray, or nest and tub configuration for efficient filling, while minimizing glass-to-glass contact. The solution, from lab-scale manual filling up to the traditional filling process, aims to enable the accelerated development and widespread commercialization of pharmaceutical and biologic treatments. Momentive designed Pur Q vial as an ultra-high-purity solution for drug storage and delivery. Made from 99.995% pure silicon dioxide (SiO2), the fused quartz vials have an exceptionally inert, nonreactive surface that virtually eliminates any risk of interaction with packaged drug formulations.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !